BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Amneal Pharmaceuticals, Inc. (AMRX) on Thursday reported third-quarter net income of $2.4 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Bridgewater, New Jersey-based company said it had net income of 1 cent. Earnings, adjusted for one-time gains and costs, came to 17 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 13 cents per share.
The pharmaceutical company posted revenue of $784.5 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $773.6 million.
Amneal expects full-year revenue in the range of $3 billion to $3.1 billion.
Amneal shares have climbed 32% since the beginning of the year. The stock has climbed 22% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRX at https://www.zacks.com/ap/AMRX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
